Global Endocrine Testing Market Size (2024 - 2029)

The endocrine testing market is projected to experience significant growth, driven by the increasing prevalence of endocrine disorders and advancements in diagnostic technologies. The demand for these tests has been heightened by the pandemic, particularly for monitoring thyroid hormone levels due to their correlation with COVID-19 severity. Additionally, the rising global awareness of early diagnosis and treatment, alongside the growing older population, is expected to further boost the market. However, challenges such as the high cost of developing testing technologies and limited awareness in some regions may hinder market expansion.

Market Size of Global Endocrine Testing Industry

 Endocrine Testing Market Size
Study Period 2019 - 2029
Market Size (2024) USD 2.66 Billion
Market Size (2029) USD 4.06 Billion
CAGR (2024 - 2029) 8.83 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Endocrine Testing Market Analysis

The Global Endocrine Testing Market size is estimated at USD 2.66 billion in 2024, and is expected to reach USD 4.06 billion by 2029, growing at a CAGR of 8.83% during the forecast period (2024-2029).

During the pandemic, many research studies have demonstrated that people with thyroid disorders are more prone to the COVID 19 infection, creating a significant demand for various endocrine tests globally to check and manage thyroid hormone levels. As per the January 2021 research study titled 'Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study', the more severe the COVID-19, the lower the TSH and TT3 levels were, with statistical significance. The degree of the decreases in TSH and TT3 levels was positively correlated with the severity of the disease. Hence, the changes in serum TSH and TT3 levels are the important manifestations of the courses of COVID-19. This might have increased the endocrine testing during the pandemic for the testing of thyroid hormone, driving the market growth.

The growing prevalence of endocrine disorders and advancements in diagnostic technologies are primarily driving the market growth. Furthermore, the growing older population, coupled with rising awareness about early diagnosis and treatment worldwide, is anticipated to boost the market growth. Endocrine testing refers to the measuring of levels of hormones secreted by the endocrine glands and the diagnosis of various disorders such as obesity, diabetes, and thyroid disease. According to the International Federation, in 2021, approximately 537 million adults were living with diabetes, and by 2045, this number will rise to 783 million. The rising diabetes across the globe will lead to increase adoption of insulin hormone testing, thereby expected to drive the market growth.

According to the World Health Organization (WHO) in March 2022, 650 million adults, 340 million teenagers, and 39 million children are obese around the world and the number is still rising. By 2025, the WHO predicts that 167 million adults and children will lose some of their health due to being overweight or obese. This will lead to further adoption of endocrine testing for thyroid function, driving the market growth.

In addition, alcohol consumption is one of the largest risk factors for various endocrine diseases and disabilities. Globally, high-income countries of the developed region have the highest alcohol consumption. This high consumption of alcohol is also serving as one of the major factors for the burden of the disease. Due to the demand for endocrine testing tools, market players are also focusing on product development and novel launches. For instance, in November 2021, Bloom Diagnostics, a Swiss medical technology company has introduced the Bloom Thyroid Test to assist identify hypothyroidism. With this test, adults can test for thyroid-stimulating hormone (TSH) using the single-use kit to identify thyroid dysfunction.

The growing prevalence of diabetes, thyroid disorders in many of the countries around the world are anticipated to further fuel the market growth. However, the high cost for the development of testing technologies and lack of awareness in underdeveloped and developing countries is expected to impede market growth over the forecast period.

Endocrine Testing Industry Segmentation

As per the scope, endocrine testing refers to devices that are used in the measurement of the level of hormones produced by the endocrine glands in the human body. Endocrine testing helps physicians to determine any endocrine disorders and further treatment of the condition or diseases. The endocrine testing market is segmented by test (thyroid test, insulin test, human chorionic gonadotropin test, prolactin test, luteinizing hormone test, progesterone test, and others), technology (immunoassay, tandem mass spectroscopy, sensor technology, and others), end-user (hospitals, clinical laboratories, and others), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above-mentioned segments.

By Test
Thyroid Test
Insulin Test
Human Chorionic Gonadotropin Test
Prolactin Test
Luteinizing Hormone Test
Progesterone Test
Other Tests
By Technology
Immunoassay
Tandem Mass Spectroscopy
Sensor Technology
Other Technologies
By End User
Hospitals
Clincal Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Endocrine Testing Market Size Summary

The global endocrine testing market is poised for significant growth, driven by the increasing prevalence of endocrine disorders and advancements in diagnostic technologies. The market is experiencing a surge in demand due to the heightened awareness of thyroid disorders, particularly following studies linking thyroid hormone levels to COVID-19 severity. This has led to a greater emphasis on endocrine testing to monitor and manage hormone levels. The rising incidence of diabetes and obesity worldwide further propels the market, as these conditions necessitate regular hormone level assessments. The market is also witnessing innovation and product development, with companies introducing novel testing solutions to meet the growing demand.

North America is expected to hold a substantial share of the market, supported by a robust healthcare infrastructure and a high prevalence of thyroid disorders. The region benefits from advancements in diagnostic technologies and new product launches, which are anticipated to drive market growth. The introduction of cost-effective screening methods and preventive treatments for thyroid diseases further bolsters the market's expansion. Globally, the market remains moderately competitive, with key players focusing on product innovations and geographical expansions to capture a larger market share. The ongoing developments in hormone testing technologies and the increasing affordability of healthcare solutions are likely to sustain the market's growth trajectory over the forecast period.

Explore More

Global Endocrine Testing Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Prevalence of Endocrine Disorders and Increasing Geriatric Population

      2. 1.2.2 Advancements in Product Technologies

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Advanced Endocrine Testing Devices

      2. 1.3.2 Lack of Awareness in Underdeveloped and Developing Countries

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Test

      1. 2.1.1 Thyroid Test

      2. 2.1.2 Insulin Test

      3. 2.1.3 Human Chorionic Gonadotropin Test

      4. 2.1.4 Prolactin Test

      5. 2.1.5 Luteinizing Hormone Test

      6. 2.1.6 Progesterone Test

      7. 2.1.7 Other Tests

    2. 2.2 By Technology

      1. 2.2.1 Immunoassay

      2. 2.2.2 Tandem Mass Spectroscopy

      3. 2.2.3 Sensor Technology

      4. 2.2.4 Other Technologies

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Clincal Laboratories

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Endocrine Testing Market Size FAQs

The Global Endocrine Testing Market size is expected to reach USD 2.66 billion in 2024 and grow at a CAGR of 8.83% to reach USD 4.06 billion by 2029.

In 2024, the Global Endocrine Testing Market size is expected to reach USD 2.66 billion.

Endocrine Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)